On Monday, May 17 th, the U.S. Supreme Court decided not to take up Sandoz’s petition for the Court to review previous lower court decisions on the launch of its biosimilar product. This included a ...
Sofusa is a drug delivery platform technology which delivers biologic therapies through the skin directly into the lymphatic system with potential to improve efficacy and safety and reduce the ...
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that competition for early-line use of Amgen/Pfizer's Enbrel and ...
EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that there has been a slight increase in ...
Yesterday, a federal appeals court upheld two patents for Amgen’s Enbrel (etanercept). Sandoz had petitioned the court to void the patents, and applied to market Erelzi, a biosimilar version of Enbrel ...
Rhodes, Greece, 5 October 2006 -- There was good news for psoriasis patients today as the latest study confirming the established safety profile of ENBREL® (etanercept) for up to 2.5 years , was ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. TRENTON, N.J. (AP) — They were the drugs ...
Biologic drugs can be joint savers for rheumatoid arthritis (RA). But even these powerful medications don't always guarantee relief from pain and stiffness. Sometimes the first biologic you try ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback